Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$0.64 - $3.15 $1,010 - $4,973
1,579 Added 2.99%
54,460 $38,000
Q4 2022

Feb 07, 2023

BUY
$2.03 - $4.28 $4,589 - $9,677
2,261 Added 4.47%
52,881 $119,000
Q3 2022

Nov 07, 2022

BUY
$3.04 - $5.14 $1,839 - $3,109
605 Added 1.21%
50,620 $162,000
Q2 2022

Jul 28, 2022

BUY
$3.17 - $6.17 $399 - $777
126 Added 0.25%
50,015 $190,000
Q1 2022

May 04, 2022

BUY
$4.16 - $13.72 $1,743 - $5,748
419 Added 0.85%
49,889 $269,000
Q4 2021

Feb 04, 2022

SELL
$10.83 - $18.41 $2,057 - $3,497
-190 Reduced 0.38%
49,470 $668,000
Q3 2021

Nov 12, 2021

BUY
$13.07 - $18.84 $11,697 - $16,861
895 Added 1.84%
49,660 $892,000
Q2 2021

Aug 02, 2021

SELL
$16.52 - $20.4 $57,126 - $70,543
-3,458 Reduced 6.62%
48,765 $837,000
Q1 2021

May 06, 2021

BUY
$16.56 - $25.46 $5,663 - $8,707
342 Added 0.66%
52,223 $1.04 Million
Q4 2020

Jan 28, 2021

SELL
$15.77 - $19.03 $28,780 - $34,729
-1,825 Reduced 3.4%
51,881 $882,000
Q3 2020

Nov 05, 2020

BUY
$16.59 - $24.79 $232,243 - $347,035
13,999 Added 35.26%
53,706 $891,000
Q2 2020

Aug 04, 2020

SELL
$16.86 - $23.44 $26,857 - $37,339
-1,593 Reduced 3.86%
39,707 $920,000
Q1 2020

May 05, 2020

SELL
$14.47 - $27.96 $845,916 - $1.63 Million
-58,460 Reduced 58.6%
41,300 $737,000
Q4 2019

Jan 27, 2020

BUY
$15.87 - $23.12 $1.06 Million - $1.55 Million
67,032 Added 204.82%
99,760 $2.15 Million
Q3 2019

Oct 31, 2019

SELL
$16.91 - $36.27 $7,169 - $15,378
-424 Reduced 1.28%
32,728 $596,000
Q2 2019

Jul 25, 2019

SELL
$31.0 - $36.3 $1.35 Million - $1.58 Million
-43,405 Reduced 56.7%
33,152 $1.18 Million
Q1 2019

Apr 29, 2019

BUY
$31.58 - $46.35 $9,031 - $13,256
286 Added 0.37%
76,557 $2.57 Million
Q4 2018

Jan 28, 2019

SELL
$30.43 - $56.65 $1.06 Million - $1.97 Million
-34,765 Reduced 31.31%
76,271 $2.51 Million
Q3 2018

Oct 29, 2018

BUY
$46.46 - $68.49 $892,543 - $1.32 Million
19,211 Added 20.92%
111,036 $6.77 Million
Q2 2018

Aug 07, 2018

BUY
$46.25 - $104.45 $2.4 Million - $5.42 Million
51,925 Added 130.14%
91,825 $4.48 Million
Q1 2018

May 14, 2018

SELL
$57.4 - $108.44 $12.9 Million - $24.4 Million
-224,768 Reduced 84.92%
39,900 $4.24 Million
Q4 2017

Feb 09, 2018

BUY
$23.02 - $60.5 $4.22 Million - $11.1 Million
183,523 Added 226.17%
264,668 $15.8 Million
Q3 2017

Nov 14, 2017

BUY
$17.79 - $24.0 $1.44 Million - $1.95 Million
81,145
81,145 $1.95 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $244M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.